Pharmaceutical company Rubicon Research on Wednesday said it has mobilised Rs 619 crore from anchor investors, ahead of its ...
IPOs span diverse sectors, including mining, insurance, pharmaceuticals, textiles, and asset management, offering investors a range of opportunities. This article outlines the key details of the ...
Explore next week's IPO calendar with major listings like Tata Capital, LG Electronics, and Midwest — see key dates and ...
The initial public offer of Rubicon Research received bids for 3,89,23,560 shares as against 1,64,55,670 shares on offer, according to stock exchange data at 17:00 IST on Friday (10 October 2025). The ...
Cardiovascular and clinical diagnostic devices maker Integris Medtech, which is backed by Singapore-registered Everstone ...
According to current GMP trends, the grey market premium for the Rubicon Research IPO has been strong for the last few days and showed minor gains when the mainboard issue opened for subscription.
Rubicon Research IPO sees 2.49x subscription and 22.89 percent GMP on second day of bidding on Friday, while Canara Robeco ...
Rubicon Researchs IPO achieved full subscription on Day 2, with significant interest from retail and institutional investors.
Rubicon Research’s ₹ IPO issue was subscribed 84% on the second day, with strong demand from retail investors. The company’s ...
Rubicon Research IPO received 84% subscription on day 2. Details on RII, QIB, and anchor investor participation.
Rubicon Research's IPO saw strong investor demand, subscribed 2.37 times. The pharma firm specializes in generics and ...
Three mainboard IPOs- Canara Robeco AMC, Rubicon Research and Canara HSBC Life Insurance- are open for investors for subscription currently, cumulatively raising over Rs 5,520 crore from investors.